FDA clears first ever 'biosimilar' drug, paves way for cheaper drugs
New drug Zarxio helps prevent infections in cancer patients undergoing chemo
Tue, Mar 10, 2015 - 5:50 AM
THE US Food and Drug Administration (FDA) has approved the first so-called biosimilar drug for use in the US, paving the way for less expensive alternatives to an entire class of complex and costly drugs.
The drug, called Zarxio, produced by Sandoz, helps prevent...